Jan 27 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4.20 4.05 5.50
(+3.7 pct) (+6.9 pct) (+3.7 pct)
Operating 595 mln 670 mln 850 mln
(-11.3 pct) (-15.5 pct) (+3.2 pct)
Recurring 620 mln 675 mln 850 mln
(-8.0 pct) (-16.8 pct) (+2.6 pct)
Net 446 mln 490 mln 600 mln
(-8.8 pct) (-15.1 pct) (-6.4 pct)
EPS 105.98 yen 116.27 yen 142.33 yen
Ann Div 35.00 yen 32.00 yen
-Q2 div NIL NIL
-Q4 div 35.00 yen 32.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T